New research suggests obesity may leave a long-lasting “memory” on the immune system, even years after weight loss.

The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from ...

Participants who were overweight or living with obesity wore the accessories for two hours every morning for six weeks and ...

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

A new study presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) shows that a 1% ...

Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) formulation of its experimental obesity drug VK2735 in adult patients with or ...

Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase III VANQUISH-1 study, which is evaluating the safety and efficacy of the subcutaneous (SC) ...

Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and ...

Pennington Biomedical Research Center, in collaboration with Vanderbilt University Medical Center, has launched a research study, the COACH trial, to test different ways to help children and their ...

New research to be presented at this year’s European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based ...